Thomas Luther

7.4k total citations · 1 hit paper
84 papers, 5.5k citations indexed

About

Thomas Luther is a scholar working on Hematology, Molecular Biology and Cancer Research. According to data from OpenAlex, Thomas Luther has authored 84 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hematology, 24 papers in Molecular Biology and 24 papers in Cancer Research. Recurrent topics in Thomas Luther's work include Blood Coagulation and Thrombosis Mechanisms (35 papers), Protease and Inhibitor Mechanisms (23 papers) and Cell Adhesion Molecules Research (22 papers). Thomas Luther is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (35 papers), Protease and Inhibitor Mechanisms (23 papers) and Cell Adhesion Molecules Research (22 papers). Thomas Luther collaborates with scholars based in Germany, United States and Netherlands. Thomas Luther's co-authors include Nigel Mackman, Peter P. Nawroth, Peter Carmeliet, Matthias Kotzsch, Viktor Magdolen, Sybille Albrecht, Angelika Bierhaus, Michael Kasper, Ingrid Müller and Bernd Engelmann and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Thomas Luther

84 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of tissue factor in embryonic blood vessel development

1996 541 citations Peter Carmeliet, Nigel Mackman et al. Nature profile →

Peers

Countries citing papers authored by Thomas Luther

Since Specialization

Citations

This map shows the geographic impact of Thomas Luther's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Luther with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Luther more than expected).

Fields of papers citing papers by Thomas Luther

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Luther. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Luther. The network helps show where Thomas Luther may publish in the future.

Co-authorship network of co-authors of Thomas Luther

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Luther. A scholar is included among the top collaborators of Thomas Luther based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Luther. Thomas Luther is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Detection of tissue factor–positive extracellular vesicles using the ExoView R100 system 2023 ·Research and Practice in Thrombosis and Haemostasis ·(unknown), Yohei Hisada, Jon Hazeldine, Victoria Bae‐Jump, Thomas Luther, Nigel Mackman, Paul Harrison	10
2	Rab31-dependent regulation of transforming growth factor ß expression in breast cancer cells 2021 ·Molecular Medicine ·(unknown), Nathalie Beaufort, Daniela Loessner, Matthias Kotzsch, Ute Reuning, Thomas Luther, Thomas Kirchner, Viktor Magdolen	5
3	Combined mRNA expression levels of members of the urokinase plasminogen activator (uPA) system correlate with disease-associated survival of soft-tissue sarcoma patients 2011 ·BMC Cancer ·Matthias Kotzsch, Viktor Magdolen, Thomas Greither, Matthias Kappler, Matthias Bache, Christine Lautenschläger, S. Füssel, Alexander W. Eckert, Thomas Luther, Gustavo Baretton, Peter Würl, Helge Täubert	11
4	Urokinase receptor splice variant uPAR-del4/5-associated gene expression in breast cancer: identification of rab31 as an independent prognostic factor 2007 ·Breast Cancer Research and Treatment ·Matthias Kotzsch, Anieta M. Sieuwerts, Marianne Großer, Axel Meye, Susanne Fuessel, Marion E. Meijer‐van Gelder, Marcel Smid, Manfred Schmitt, Gustavo Baretton, Thomas Luther, Viktor Magdolen, John A. Foekens	47
5	Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancer 2005 ·European Journal of Cancer ·Matthias Kotzsch, Juliane Farthmann, Axel Meye, Susanne Fuessel, Gustavo Baretton, Vivianne C. G. Tjan‐Heijnen, Manfred Schmitt, Thomas Luther, Fred C.G.J. Sweep, Viktor Magdolen, Paul N. Span	40
6	Proteolytic Regulation of the Urokinase Receptor/CD87 on Monocytic Cells by Neutrophil Elastase and Cathepsin G 2004 ·The Journal of Immunology ·Nathalie Beaufort, Dominique Leduc, Jean-Claude Rousselle, Viktor Magdolen, Thomas Luther, Abdelkader Namane, Michel Chignard, Dominique Pidard	59
7	Perfluorocarbon attenuates response of concanavalin A-stimulated mononuclear blood cells without altering ligand-receptor interaction 2004 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·(unknown), Thomas Luther, Matthias Kotzsch, Lilla Knels, Thea Koch	7
8	Validation of a novel tissue factor assay in experimental human endotoxemia 2003 ·Thrombosis Research ·Claudia Marsik, Peter Quehenberger, Nigel Mackman, Bjarne Østerud, Thomas Luther, Bernd Jilma	13
9	Natural and Synthetic Inhibitors of The Tumor-Associated Serine Protease Urokinase-Type Plasminogen Activator 2002 ·Advances in experimental medicine and biology ·Viktor Magdolen, (unknown), S. Sperl, Bernd Muehlenweg, Thomas Luther, Olaf G. Wilhelm, (unknown), H. Graeff, Ute Reuning, Manfred Schmitt	14
10	High Level Synthesis of Recombinant Soluble Urokinase Receptor (CD87) by Ovarian Cancer Cells Reduces Intraperitoneal Tumor Growth and Spread in Nude Mice 2001 ·Biological Chemistry ·Veronika Lutz, Ute Reuning, Achim Krüger, Thomas Luther, S Pildner von Steinburg, H. Graeff, Martina Schmitt, Olaf G. Wilhelm, (unknown)	32
11	Functional implications of tissue factor localization to cell-cell contacts in myocardium 2000 ·The Journal of Pathology ·Thomas Luther, Dag‐Daniel Dittert, Matthias Kotzsch, Jonathan Erlich, Sybille Albrecht, Nigel Mackman, Martin M�ller	31
12	Lesion associated expression of urokinase-type plasminogen activator receptor (uPAR, CD87) in human cerebral malaria 2000 ·Journal of Neuroimmunology ·(unknown), Martin H. Deininger, Peter G. Kremsner, Viktor Magdolen, Thomas Luther, Richard Meyermann, Hermann J. Schluesener	38
13	Tumor Necrosis Factor Induces Tumor Necrosis via Tumor Necrosis Factor Receptor Type 1-Expressing Endothelial Cells of the Tumor Vasculature 2000 ·American Journal Of Pathology ·Benjamin Stoelcker, (unknown), Thomas Hehlgans, Horst Bluethmann, Thomas Luther, Daniela N. Männel	57
14	A rapid and versatile method for harnessing scFv antibody fragments with various biological effector functions 2000 ·Journal of Immunological Methods ·Wijnand Helfrich, Hidde J. Haisma, (unknown), Thomas Luther, V J J Bom, Jantine L. Westra, (unknown), (unknown), Grietje Molema, Lou de Leij	21
15	Endophthalmitis 1999 ·Der Ophthalmologe ·Thomas Luther, Karl Ulrich Bartz‐Schmidt	4
16	Low levels of tissue factor are compatible with development and hemostasis in mice. 1998 ·Journal of Clinical Investigation ·Graham C. Parry, Jonathan Erlich, Peter Carmeliet, Thomas Luther, Nigel Mackman	172
17	Insights in Vessel Development and Vascular Disorders Using Targeted Inactivation and Transfer of Vascular Endothelial Growth Factor, the Tissue Factor Receptor, and the Plasminogen System 1997 ·Annals of the New York Academy of Sciences ·Peter Carmeliet, Lieve Moons, Mieke Dewerchin, Nigel Mackman, Thomas Luther, Georg Breier, Victoria A. Ploplis, Martin Müller, András Nagy, Edward F. Plow, Robert D. Gerard, Thomas S. Edgington, Werner Risau, Désiré Collen	93
18	In Search of a Gene for Hereditary Cholestasis 1996 ·Biochemical and Molecular Medicine ·(unknown), Laura N. Bull, Noureddine Lomri, (unknown), Thomas Luther, Peter S. Hammerman, (unknown), Nelson B. Freimer, Bruce F. Scharschmidt	5
19	Role of tissue factor in embryonic blood vessel development breakdown → 1996 ·Nature ·Peter Carmeliet, Nigel Mackman, Lieve Moons, Thomas Luther, Pierre Gressèns, (unknown), (unknown), Michael Kasper, Georg Breier, Philippe Evrard, (unknown), Werner Risau, Thomas S. Edgington, Désiré Collen	541
20	Constitutive tissue factor expression of human breast cancer cell line MCF-7 is modulated by growth factors 1992 ·European Journal of Cancer ·(unknown), Thomas Luther, Sybille Albrecht, Matthias Kotzsch, Martín Müller	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact